Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods

European Journal of Haematology

Volumn 71, Issue 6, 2003, Pages 403-407

  Milman, Nils ^a,c   Koefoed, Pernille ^a   Pedersen, Palle ^b   Nielsen, Finn Cilius ^a   Eiberg, Hans ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

Denmark; Genotypes; Haemochromatosis; Mutations

Indexed keywords

TRANSFERRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC IDENTIFICATION; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH SURVEY; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON ABSORPTION; IRON STORAGE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MUTATOR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; DENMARK; FEMALE; GENE FREQUENCY; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 0345393133     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-4441.2003.00156.x     Document Type: Article

References (50)

1. VON RECKLINGHAUSEN FD. Über Hämochromatose. Tageblatt der Versammlung Deutscher Naturforscher und Ärzte, Heidelberg. 1889;62:324-325.
2. SHELDON JH. Haemochromatosis. London: Oxford University Press, 1935.
3. SADDI R, FEINGOLD J. Idiopathic haemochromatosis: an autosomal recessive disease. Clin Genet 1974;5:234-241.
4. SIMON M, BOUREL M, FAUCHET R, GENETET B. Association of HLA A3 and HLA B14 antigens with idiopathic haemochromatosis. Gut 1976;17:332-334.
5. BOTHWELL TH, CHARLTON RW, MOTULSKY AG. Hemochromatosis. In SCRIVER CR, BEAUDET AL, SLY WS, VALLE D, Eds. The Molecular and Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995:2237-2269.
6. ADAMS PC, SPEECHLEY M, KERTESZ AE. Long term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-372.
7. NIEDERAU C, FISHER R, PURSCHEL A, STREMMEL W, HAUSSINGER D, STROHMEYER G. Long term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
8. MILMAN N, PEDERSEN P, Á STEIG T, BYG K-E, GRAUDAL N, FENGER K. Hereditary haemochromatosis in Denmark: epidemiology 1948-1985, factors of significance for long-term survival, and causes of death in 179 patients with clinically overt disease. Ann Hematol 2001;67:23-29.
9. DADONE M, KUSHNER JP, EDWARDS CQ, BISHOP DT, SKOLNICK MH. Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982;78:196-207.
10. MILMAN N. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Eur J Haematol 1991;47:292-298.
11. FEDER JN, GNIRKE A, THOMAS W et al. A novel MCH class-I gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
12. MILMAN N. Inheritance of hemochromatosis: family studies. In BARTON JC, EDWARDS CQ, Eds. Hemochromatosis. Genetics, pathophysiology, diagnosis, and treatment. Cambridge: Cambridge University Press, 2000:15-41.
13. WORWOOD M. Haemochromatosis. Clin Lab Haem 1998;20:65-75.
14. MILMAN N, PEDERSEN P. Evidence that the Cys282Tyr mutation of the HFE gene originated among the population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003;64:36-47.
15. ELLERVIK C, MANDRUP-POULSEN T, NORDESTGAARD BG et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 2001;358:1405-1409.
16. MILMAN N. Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 1991;38:385-393.
17. MILMAN N, GRAUDAL N, NIELSEN LS, FENGER K. HLA determinants in 70 Danish patients with idiopathic haemochromatosis. Clin Genet 1988;33:286-292.
18. KOEFOED P, DALHOFF K, DISSING J, KRAMER I, MILMAN N, PEDERSEN P, SIMONSEN K, TYGSTRUP N, NIELSEN FC. HFE-mutations and hemochromatosis in patients admitted for HFE-genotyping. Scand J Clin Lab Invest 2002;62:527-536.
19. MILMAN N, PEDERSEN P, Á STEIG T, VEDEL G. Frequency of the hereditary hemochromatosis allele in different populations. Comparison between previous phenotypic methods and novel genotypic methods. Int J Hematol 2003;77:48-54.
20. WIGGERS P, DALHØJ J, KIÆR H et al. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991;230:265-270.
21. OLSSON KS, MARSELL R, RITTER B, OLANDER B, ÅKERBLOM E, ÔSTERGÅRD H et al. Iron deficiency and iron overload in Swedish male adolescents. J Intern Med 1995;237:187-194.
22. BELL H, THORDAL C, RAKNERUD N, HANSEN T, BOSNES V, HALVORSEN R et al. Prevalence of haemochromatosis among first-time and repeat blood donors in Norway. J Hepatol 1997;26:272-279.
23. JONSSON JJ, JOHANNESSON GM, SIGFUSSON N, MAGNUSSON B, THJODLEIFSSON B, MAGNUSSON S. Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol 1991;44:1289-1297.
24. BELL H, BERG JP, UNDLIEN DE et al. The clinical expression of haemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary haemochromatosis even in HFE C282Y negative subjects. Scand J Gastroenterol 2000;35:1301-1307.
25. CARDOSO EM, STAL P, HAGEN K et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203-208.
26. WORWOOD M, WALLACE DF, DOOLEY JS et al. The UK haemochromatosis consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-844.
27. NIELSEN P, CARPINTEIRO S, FISCHER R, CABEDA JM, PORTO G, GABBE EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects. Br J Haematol 1998; 103:842-845.
28. DATZ C, LALLOZ MRA, VOGEL W et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997;27:773-779.
29. BOROT NN, ROTH MP, MALFROY L et al. Mutations in the MCH class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997;45:320-324.
30. MURA C, RAGUENES O, FEREC C. HFE mutation analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93: 2502-2505.
31. JOUANOLLE AM, FERGELOT P, GANDON G et al. A candidate gene for haemochromatosis: frequency of the C282Y and H63D mutations. Hum Genet 1997;100:544-547.
32. PIPERNO A, SAMPIETRO M, PIETRANGELO A et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
33. CARELLA M, D'AMBROSIO L, TOTARO A et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Human Genet 1997;60:828-832.
34. JAZWINSKA EC, CULLEN LM, BUSFIELD F, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-251.
35. ADAMS PC, CHAKRABARTI S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-323.
36. BEUTLER E, GELBART T, WEST C et al. Mutation analysis in hereditary hemochromatosis. Blood Cell Mol Dis 1996;22: 187-194.
37. MERRYWEATHER-CLARKE AT, POINTON JJ, JOUANOLLE AM, ROCHETTE J, ROBSON KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-198.
38. AQUILAR-MARTINEZ P, BISMUTH M, PICOT MC et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001; 48:836-842.
39. MATTMAN A, HUNTSMAN D, LOCKITCH G, LANGLOIS S, BUSKARD N, RALSTON D et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 2002;100:1075-1077.
40. GOCHEE PA, POWELL LW, CULLEN DJ, DU SD, ROSSI E, OLYNYK JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-651.
41. CAMASCHELLA C, ROETTO A, DE GOBBI M. Juvenile hemochromatosis. Semin Hematol 2002;39:242-248.
42. CAMASCHELLA C, ROETTO A, CALI A, DE GOBBI M, GAROZZO G, CARELLA M et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
43. PONKA P. Rare causes of hereditary iron overload. Semin Hematol 2002;39:249-262.
44. NJAJOU OT, VAESSEN N, JOOSSE M, BERGHUIS B, VAN DONGEN JW, BREUNING MH et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-214.
45. MONTOSI G, DONOVAN A, TOTARO A, GARUTI C, PIGNATTI E, CASSANELLI S et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
46. WALLACE DF, PEDERSEN P, DIXON JL, STEPHENSON P, SEARLE JW, POWELL LW et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-694.
47. DEVALIA V, CARTER K, WALKER AP, PERKINS SJ, WORWOOD M, MAY A et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-697.
48. CAZZOLA M, CREMONESI L, PAPAIOANNOU M, SORIANI N, KIOUMI A, CHARALAMBIDOU A et al. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) Br J Haematol 2002;119:539-546.
49. ROETTO A, MERRYWEATHER-CLARKE AT, DARAIO F, LIVESEY K, POINTON JJ, BARBABIETOLA G et al. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4 Blood 2002;100:733-734.
50. ROETTO A, PAPANIKOLAOU G, POLITOU M, ALBERTI F, GIRELLI D, CHRISTAKIS J et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-22.